Glutaminyl thiazolidine or glutaminyl pyrrolidine in combination with other hypoglycemic agents for glycemic control (original) (raw)

Glucuretics: A New Class of Drug for the Treatment of Type 2 Diabetes

Md Azizul Hoque

KYAMC Journal, 2017

View PDFchevron_right

Oral Anti-diabetic Agents

Tahniyah Haq

Bangladesh Medical Journal, 2017

View PDFchevron_right

Oral glucose lowering drugs in type 2 diabetic patients with chronic kidney disease

Daniel Braga

HORMONES, 2013

View PDFchevron_right

Glucosyl anthranilate

Haoyan Liu

Acta Crystallographica Section E Structure Reports Online, 2009

View PDFchevron_right

Hyponatraemia Associated with Psychotropic Medications

Jorge Sotelo

Adverse Drug Reactions and Toxicological Reviews, 2002

View PDFchevron_right

Bedtime Dosing of Glyburide and the Treatment of Type II Diabetes Mellitus

Mark Bustamante

The American Journal of the Medical Sciences, 1994

View PDFchevron_right

A Pharmacist-Driven Glycemic Control Protocol to Reduce the Rate of Severe Hypoglycemia in High-Risk Patients

angie case

Hospital Pharmacy, 2020

View PDFchevron_right

Diabetes Intervention : Achieving Tight Glycemic Control Through Combination Therapy

Christopher Dezii

2001

View PDFchevron_right

Current pharmacological treatment of gastroparesis

S. Salvatore

Expert Opinion on Pharmacotherapy, 2004

View PDFchevron_right

Thiazolidinediones and PPAR orchestra as antidiabetic agents: From past to present

Venkatesan Jayaprakash

European journal of medicinal chemistry, 2017

View PDFchevron_right

Treatment Intensification and Blood Glucose Control Among Hospitalized Diabetic Patients

Maria Shubina

Journal of General Internal Medicine, 2007

View PDFchevron_right

Pharmacologic Glycemic Management of Type 2 Diabetes in Adults

Kaberi Dasgupta

Canadian journal of diabetes, 2018

View PDFchevron_right

30ièmes Journées Franco-Belges de Pharmacochimie

Jean-michel Bolla

Pharmaceuticals, 2016

View PDFchevron_right

Proceedings Of MPS-National Pharmacists Convention 2023

nahlah elkudssiah ismail

Malaysian journal of pharmacy, 2023

View PDFchevron_right

Contents, Actions and Efficacy of Weight Reduction Medications Available in the Drugs Markets, Benghazi, Libya

Ali Elmabsout

Asian Journal of Basic Science & Research, 2023

View PDFchevron_right

Is Glycemic Control the Primary Goal in Diabetes Treatment?

Panayota Mitrou

International Journal of Biomedical and Clinical Analysis, 2023

View PDFchevron_right

A food supplement having Adiponectin Agonist properties

Anil Mungikar

2022

View PDFchevron_right

Advanced Glycation End-Products In Diabetes Complications

Pranav Kumar Prabhakar

European Journal of Molecular & Clinical Medicine, 2020

View PDFchevron_right

5,6-Diarylanthranilo-1,3-dinitriles as a new class of antihyperglycemic agents

Salil Pratap singh

Bioorganic & Medicinal Chemistry Letters, 2009

View PDFchevron_right

Safety and Efficacy of Gliclazide as Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Trials

Reinold Gans

Plos One, 2014

View PDFchevron_right

Tight glucose control and hypoglycemia

Jean-charles Preiser

Critical Care Medicine, 2008

View PDFchevron_right

Evaluation of Guidelines on Diabetes Medication

Luca Monge

Annals of Internal Medicine, 2012

View PDFchevron_right

Celiac disease and dietetic products for persons intolerant to gluthen

Ivan Stankovic

Arhiv za farmaciju, 2017

View PDFchevron_right

Antidiabetic Medications and Polypharmacy

Emily Peron

Clinics in Geriatric Medicine, 2015

View PDFchevron_right

Editorial: Advanced approaches in the diagnosis and treatment of diabetes mellitus and secondary complications

Pranav Kumar Prabhakar

Frontiers in Endocrinology, 2023

View PDFchevron_right

Medication and exercise interactions: considering and managing hypoglycemia risk

Jacqueline Shahar

Diabetes spectrum : a publication of the American Diabetes Association, 2015

View PDFchevron_right

Antihypertensive agents, serum lipoproteins and glucose metabolism

Johan Rosman

The American Journal of Cardiology, 1991

View PDFchevron_right

Management of Hyperglycemic Crises in Patients With Diabetes

Eugene Barrett

Diabetes Care, 2001

View PDFchevron_right

New drugs for non‐alcoholic steatohepatitis

Cristiane Villela-nogueira

Liver International, 2020

View PDFchevron_right

Immune Modulating Drugs Used in Skin Disease and Most Bothering Side Effects

MANAL MURAD

International Journal of Advanced Research, 2020

View PDFchevron_right

Glucagon-like peptide 1 (GLP-1)

Wolfgang Langhans

Molecular Metabolism, 2019

View PDFchevron_right

Making a case for domperidone in the treatment of gastrointestinal motility disorders

Naveed Ahmad

Current Opinion in Pharmacology, 2006

View PDFchevron_right

Hypertensive Patients; Impaired Glucose Tolerance

darshan kumar

The Professional Medical Journal

View PDFchevron_right

Ketofol as induction agent in diabetic patients

samina aslam

The professional medical journal, 2022

View PDFchevron_right

From pharmaceutics to pharmaceutical care in nutritional support

Gil Hardy

Clinical Nutrition, 1995

View PDFchevron_right